Associated Papers
Protein aggregation in neurodegenerative diseases.
Wang J et al.
Chinese Medical Journal, 2025
Targeting Protein Misfolding and Aggregation as a Therapeutic Perspective in Neurodegenerative Disorders.
Sidoryk-Węgrzynowicz M et al.
International Journal of Molecular Sciences, 2024
Aggregation of Disordered Proteins Associated with Neurodegeneration.
Tsoi PS et al.
International Journal of Molecular Sciences, 2023
Protein Misfolding and Aggregation: The Relatedness between Parkinson's Disease and Hepatic Endoplasmic Reticulum Storage Disorders.
Padilla-Godínez FJ et al.
International Journal of Molecular Sciences, 2021
Studying the effect of alpha-synuclein and Parkinson's disease linked mutants on inter pathway connectivities.
Sen S et al.
Scientific Reports, 2021
Hydration Thermodynamics of Familial Parkinson's Disease-Linked Mutants of α-Synuclein.
Aggarwal L et al.
Journal of Chemical Information and Modeling, 2021
Pathogenic Mutations Differentially Regulate Cell-to-Cell Transmission of α-Synuclein.
Guan Y et al.
Frontiers in Cellular Neuroscience, 2020
Autonomic dysfunction in genetic forms of synucleinopathies.
Chelban V et al.
Movement Disorders : Official Journal of the Movement Disorder Society, 2018
Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.
Coskuner-Weber O et al.
International Journal of Molecular Sciences, 2018
Molecular Genetics of Neurodegenerative Dementias.
Hinz FI et al.
Cold Spring Harbor Perspectives in Biology, 2017
Alpha-synuclein at the intracellular and the extracellular side: functional and dysfunctional implications.
Ottolini D et al.
Biological Chemistry, 2017
LK6/Mnk2a is a new kinase of alpha synuclein phosphorylation mediating neurodegeneration.
Zhang S et al.
Scientific Reports, 2015
Glial A30P alpha-synuclein pathology segregates neurogenesis from anxiety-related behavior in conditional transgenic mice.
Marxreiter F et al.
Neurobiology of Disease, 2013
Tissue transglutaminase modulates alpha-synuclein oligomerization.
Segers-Nolten IM et al.
Protein Science : a Publication of the Protein Society, 2008
alpha-Synucleinopathy models and human neuropathology: similarities and differences.
Kahle PJ
Acta Neuropathologica, 2008
Autosomal dominant Parkinson's disease and the route to new therapies.
Morris HR
Expert Review of Neurotherapeutics, 2007
Stabilization of alpha-synuclein protein with aging and familial parkinson's disease-linked A53T mutation.
Li W et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience, 2004
Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein.
Okochi M et al.
The Journal of Biological Chemistry, 2000
Motor dysfunction and gliosis with preserved dopaminergic markers in human alpha-synuclein A30P transgenic mice.
Gomez-Isla T et al.
Neurobiology of Aging, 0